Adverse events associated with JAK inhibitors in 126,815 reports from the WHO pharmacovigilance database.
Hoisnard L, Lebrun-Vignes B, Maury S, Mahevas M, El Karoui K, Roy L, Zarour A, Michel M, Cohen JL, Amiot A, Claudepierre P, Wolkenstein P, Grimbert P, Sbidian E.
Hoisnard L, et al. Among authors: sbidian e.
Sci Rep. 2022 May 3;12(1):7140. doi: 10.1038/s41598-022-10777-w.
Sci Rep. 2022.
PMID: 35504889
Free PMC article.